Format

Send to

Choose Destination
J Clin Res Pediatr Endocrinol. 2020 Mar 19;12(1):109-112. doi: 10.4274/jcrpe.galenos.2019.2018.0198. Epub 2019 Apr 10.

Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the CYP19A1 Gene

Author information

1
Ege University Faculty of Medicine, Department of Pediatric Endocrinology, İzmir, Turkey
2
Ege University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Genetics, İzmir, Turkey
3
Ege University Faculty of Medicine, Department of Medical Genetics, İzmir, Turkey

Abstract

Aromatase deficiency rarely causes a 46,XX sexual differentiation disorder. The CYP19A1 gene encodes the aromatase enzyme which catalyses the conversion of androgens to oestrogens. In cases with 46,XX karyotype, mutations in the CYP19A1 gene can lead to disorders of sex development. Clinical findings in aromatase deficiency vary depending on the degree of deficiency. The effect of increased androgens, including acne, cliteromegaly and hirsutism, can be observed in mothers with placental aromatase deficiency. A decrease in maternal virilisation symptoms is observable in the postpartum period. It is rarely reported that there is no virilization in pregnancy. In this study, two 46,XX sibling having the p.R115X (c.343 C>T) novel pathogenic variant in the CYP19A1 gene and raised as different genders, with no maternal virilisation during pregnancy, are presented. In conclusion, 46,XX virilised females should be examined in terms of aromatase deficiency once congenital adrenal hyperplasia has been excluded, even if there is no history of maternal virilisation during pregnancy.

KEYWORDS:

46; XX disorder of sex development; aromatase deficiency; CYP19A1 gene

Free full text

Supplemental Content

Full text links

Icon for Galenos Yayinevi
Loading ...
Support Center